15 juni 2007: Bron: What doctors don't tell you.

Gardasil, het nieuwe vaccin tegen het HPV virus, de veroorzaker van vooral baarmoederkanker en baarmoederhalskanker zou al bij drie tienermeisjes in Australië tot de dood hebben geleid. Bovendien schijnen veel meisjes veel last te hebben van ernstige bijwerkingen. Dit bericht What doctors don't tell you in hun nieuwsbrief van 14 juni en zij baseren hun beweringen op een studie gepubliceerd in BMJ = The British Medical Journal van 14 juni 2007. Achtereenvolgens de eerste 150 woorden van de studie die hiervan melding maakt en het artikel van What Doctors don't tell You. In Pubmed is welgeteld èèn zinnetje als abstract weergegeven en wordt met geen woord gerept over sterftegevallen.

BMJ 2007;334:1195 (9 June), doi:10.1136/bmj.39238.479479.94 Observations
Medicine and the media
Fainting schoolgirls wipe $A1bn off market value of Gardasil producer
Simon Chapman, professor of public health, Ross MacKenzie, research officer

School of Public Health, University of Sydney Correspondence to:S Chapman sc@med.usyd.edu.au

Public health workers need to be as vigilant against one-sided media coverage of vaccination as they were against the disinformation spread by the tobacco industry

The first 150 words of the full text of this article appear below.

On 22 May news broke that 25 girls at a Catholic high school in Melbourne who had just had their first injection of Gardasil, the vaccine against human papillomavirus (HPV), presented to the school's sick bay with symptoms that included headache, nausea, and dizziness. CSL, the vaccine's Australian developer, reports that four pupils were sent to hospital for further examination. It said, "One had chest pain and palpitations; she had a past history of these symptoms. She was discharged the same day. The second had hyperventilation paraesthesiae and was sent home the same day. The third and fourth had neurological symptoms and were admitted. The fourth girl had reported progressive muscular weakness. Overnight both got better and were seen by the neurologist in the morning who diagnosed non-organic illness."

Other than the mother of one girl, who dismissed suggestions of the episode's psychogenic origin as "absolute rubbish" during a television . . .

HPV Vaccine: Gardasil may be a killer
14 June 2007
The HPV vaccine – which is being given to girls aged between 11 and 12 to prevent cervical cancer in later life – may be a killer. So far three young girls have died after being vaccinated, and there have been 1,637 adverse reactions reported in under a year.

In Australia 25 girls at the same school who had been given their first HPV vaccine last month experienced headache and nausea, and four ended up in hospital.

The vaccine, Gardasil, has courted controversy since it was approved for use last year. Some states in the USA have decided to make the vaccine compulsory, which has caused an outcry among parents who see the vaccine as a license for sexual relationships outside of marriage.

Gardasil is supposed to protect against human papillomavirus types 6, 11, 16 and 18, which cause most cervical cancers and genital warts.

A public interest group, Judicial Watch, discovered the extent of the adverse reactions only when they made a request to the Food and Drug Administration (FDA) under the Freedom of Information Act.

Presumably the FDA would have preferred to have stayed silent rather than alert the public about a vaccine that may need more safety trials.

(Source: British Medical Journal, 2007; 334: 1182). E-news broadcast 14 June 2007 No.368

Plaats een reactie ...

Reageer op "Vaccins tegen kanker: Gardasil , het nieuwe vacin tegen het HPV virus heeft al drie tienermeisjes het leven gekost en veroorzaakt ernstige bijverschijnselen bij vele andere meisjes."


Gerelateerde artikelen
 

Gerelateerde artikelen

Meer bijwerkingen door immuuntherapie >> Immuuntherapie met anti-PD >> Dieet - voedingspatroon dat >> Tisotumab vedotin plus chemo >> Dendritische celtherapie heeft >> sTILs - tumor infiltrating >> CAR-T cel therapie is een >> Verkoudheidsvirus Delta-24-RGD >> Immuuntherapie met het gemoduleerde >> lenvatinib samen met pembrolizumab >>